CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis

Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo

Cancer Research and Treatment. 2021;53(3):703-713. Published online 2020 December 1 DOI: https://doi.org/10.4143/crt.2020.805

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis

Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo

Cancer Research and Treatment. 2021;53(3):703-713

Link1

Link2 Link3

187P Optimal treatment strategy of first-line oxaliplatin (Oxa)- containing therapy in metastatic colorectal cancer (mCRC): A trial-level meta-analysis

T. Moriwaki, M. Gosho, A. Sugaya, T. Yamada, Y. Yamamoto, I. Hyodo

Annals of Oncology. 2016;27:ix58-ix59

Link1 Link2

Retrospective Analysis of S-1 plus Bevacizumab as Maintenance Therapy after Induction of S-1 and Oxaliplatin (SOX) plus Bevacizumab as First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer

Yasutake Uchima, Naoki Aomatsu, Gen Tsujio, Takehiko Iwauchi, Shinji Matsutani, Hiroto Tanaka, Hironari Miyamoto, Takuma Okada, Shigeaki Kurihara, Toshiki Hirakawa, Keiichiro Hirata, Junya Morimoto, Shigehito Yamagata, Kazuhiro Takeuchi

Journal of Cancer Therapy. 2020;11(02):35-43

Link1 Link2

Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy

Stephen Johnston, Kathleen Wilson, Helen Varker, Elisabetta Malangone-Monaco, Paul Juneau, Ellen Riehle, Sacha Satram-Hoang, Nicolas Sommer, Sarika Ogale

Clinical Colorectal Cancer. 2017;16(4):386-396.e1

Link1 Link2

Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal Cancer

Narikazu Boku, Shun Yamamoto

Clinical Colorectal Cancer. 2018;17(4):251-254

Link1 Link2

Continuing Single-Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First-Line Treatment of Metastatic Colorectal Cancer

Eduardo Díaz-Rubio, Filippo Pietrantonio, Filippo Braud

The Oncologist. 2012;17(11):1426-1428

Link1 Link2 Link3

Link4

Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting

Barry V. Fortner, Lee S. Schwartzberg, Edward J. Stepanski, Arthur C. Houts

Supportive Cancer Therapy. 2007;4(4):233-240

Link1 Link2

Effect of Application and Intensity of Bevacizumab-based Maintenance After Induction Chemotherapy With Bevacizumab for Metastatic Colorectal Cancer: A Meta-analysis

Alexander Stein, Carsten Schwenke, Gunnar Folprecht, Dirk Arnold

Clinical Colorectal Cancer. 2016;15(2):e29-e39

Link1 Link2

A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer

Zev Wainberg, J. Randolph Hecht

Clinical Colorectal Cancer. 2006;5(5):363-367

Link1 Link2

Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer

Jude Khatib, Radhika Kainthla

Current Colorectal Cancer Reports. 2020;16(4):89-95

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.